The company
Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
DNA stood above a rising 150-day average in 5 of the last 52 weekly readings, including each of the last 2 weeks. It is 21.8% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $7.3M
- Officials’ trades on record
- 0
- Institutions holding
- 175 (+11)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Steven P. CoenSee remarks | sold | 2,403at $15.00 | 5 Oct 2026filed 7 Oct 2026 |
| Christian O. HenryDirector | sold | 5,000at $7.08 | 15 Sep 2026filed 16 Sep 2026 |
| Steven P. CoenSee remarks | sold | 330at $6.98 | 24 Aug 2026filed 25 Aug 2026 |
| Steven P. CoenSee remarks | sold | 752at $7.90 | 17 Jul 2026filed 20 Jul 2026 |
| Steven P. CoenSee remarks | sold | 307at $8.33 | 22 May 2026filed 26 May 2026 |
| Steven P. CoenSee remarks | sold | 324at $7.95 | 17 Apr 2026filed 20 Apr 2026 |
| Steven P. CoenSee remarks | sold | 33,171at $6.41 | 13 Apr 2026filed 14 Apr 2026 |
| Reshma P. ShettySee remarks | sold | 124,727at $6.43 | 10 Apr 2026filed 13 Apr 2026 |
| Barry Canton10% owner | sold | 124,727at $6.43 | 10 Apr 2026filed 13 Apr 2026 |
| Jason R. KellySee remarks | sold | 109,767at $6.40 | 9 Apr 2026filed 10 Apr 2026 |
| Barry Canton10% owner | sold | 13,116at $6.40 | 9 Apr 2026filed 10 Apr 2026 |
| Reshma P. ShettySee remarks | sold | 13,116at $6.40 | 9 Apr 2026filed 10 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,282,903$42.4M | +640,556+17.6% |
| VIKING GLOBAL INVESTORS LPunchanged · filed 14 Aug 2026 | 3,577,128$35.4M | 00.0% |
| Erste Asset Management GmbHadded · filed 28 Jul 2026 | 2,536,939$25.9M | +589,211+30.3% |
| BAILLIE GIFFORD & COunchanged · filed 6 Aug 2026 | 2,391,649$23.7M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,087,293$20.7M | +172,865+9.0% |
| Anchorage Capital Group, L.L.C.unchanged · filed 14 Aug 2026 | 1,746,363$17.3M | 00.0% |
| Legal & General Group Plcadded · filed 14 Aug 2026 | 1,669,419$16.5M | +7,832+0.5% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 1,472,370$14.6M | +125,711+9.3% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,222,016$12.1M | +212,654+21.1% |
| FORBES J M & CO LLPreduced · filed 20 Jul 2026 | 999,911$9.9M | -28,480−2.8% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.